| 4.89 0.61 (14.25%) | 06-12 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.4 | 1-year : | 7.44 |
| Resists | First : | 5.48 | Second : | 6.36 |
| Pivot price | 5.03  |
|||
| Supports | First : | 4.05 | Second : | 3.36 |
| MAs | MA(5) : | 4.55 |
MA(20) : | 5.21 |
| MA(100) : | 6.45 |
MA(250) : | 5.77 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 27.6 |
D(3) : | 16.4 |
| RSI | RSI(14): 43.5 |
|||
| 52-week | High : | 11.17 | Low : | 2.48 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ YI ] has closed above bottom band by 46.2%. Bollinger Bands are 5.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 5.14 - 5.18 | 5.18 - 5.21 |
| Low: | 4.38 - 4.41 | 4.41 - 4.45 |
| Close: | 4.9 - 4.97 | 4.97 - 5.03 |
Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a comprehensive online-to-offline (O2O) ecosystem. Its operations are structured across both business-to-business (B2B) and business-to-consumer (B2C) channels. The company facilitates the sale of a wide array of medical and wellness products, reaching customers through its online retail channels as well as wholesale and retail pharmacy networks. This extensive product catalog encompasses prescription medications, over-the-counter drugs (both Western and traditional Chinese), dietary supplements like vitamins, optical products such as contact lenses, various medical supplies and devices (e.g., bandages, thermometers), personal care items (including skincare, birth control, and sexual wellness products), and infant care essentials. Beyond product sales, 111, Inc. provides value-added services to consumers, such as online consultation and electronic prescription fulfillment. For its business partners, the company manages an online marketplace enabling third-party vendors to directly supply pharmacies. It further supports its "1 Pharmacy" clients – comprising pharmacies and wholesalers – with online loan application services, alongside offering data and supply chain integration solutions. Its operational scope also extends to critical back-end functions, including warehousing, logistics management, procurement, research and development, consulting, as well as software development and IT support. As of December 31, 2021, its physical footprint included 14 retail pharmacies operating under the "Yi Hao Pharmacy" brand across several key regions: Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan. The company caters to a diverse clientele, encompassing individual consumers, pharmacies, pharmaceutical manufacturers and distributors, medical practitioners, and insurance providers.
Fri, 12 Jun 2026
ADRs Advance; 111 Inc. Climbs 14% - Moomoo
Fri, 12 Jun 2026
Director Sun Jian David trades RSUs at 111, Inc. (NASDAQ: YI) - Stock Titan
Thu, 11 Jun 2026
Large RSU grants and follow-on share sales by 111, Inc. (YI) director - Stock Titan
Tue, 09 Jun 2026
YI (NASDAQ: YI) Form 144: Insider sale of 4,986 ADS noted - Stock Titan
Thu, 04 Jun 2026
111: Q1 Earnings Snapshot - WKYC
Thu, 04 Jun 2026
Press Release: 111, Inc. Announces First Quarter 2026 Unaudited Financial Results - Moomoo
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 5 (M) |
| Shares Float | 93 (M) |
| Held by Insiders | 8.3 (%) |
| Held by Institutions | 0.3 (%) |
| Shares Short | 14 (K) |
| Shares Short P.Month | 25 (K) |
| EPS | -1.13 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -11.78 |
| Profit Margin | -0.6 % |
| Operating Margin | -0.1 % |
| Return on Assets (ttm) | -0.1 % |
| Return on Equity (ttm) | -7.6 % |
| Qtrly Rev. Growth | -26.8 % |
| Gross Profit (p.s.) | 72.72 |
| Sales Per Share | 2415.38 |
| EBITDA (p.s.) | 1.81 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 119 (M) |
| Levered Free Cash Flow | 229 (M) |
| PE Ratio | -4.44 |
| PEG Ratio | 0 |
| Price to Book value | -0.43 |
| Price to Sales | 0 |
| Price to Cash Flow | 0.21 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|